AI assistant
Sending…
Vistin Pharma — Director's Dealing 2021
May 19, 2021
3782_dirs_2021-05-19_a755772a-0ebb-41ab-b19e-f5aa8b2d5e94.html
Director's Dealing
Open in viewerOpens in your device viewer
Vistin Pharma ASA: Mandatory notification of trade
Vistin Pharma ASA: Mandatory notification of trade
Hilde Merete Hagen, VP Quality & regulatory Affairs in Vistin Pharma ASA, and a
primary insider, has on 18th of May 2021 sold 14 182 shares in Vistin Pharma ASA
at an average price of NOK 24.0 per share.
Following this transaction Hilde Merete Hagen do not hold any shares in Vistin
Pharma ASA.
More from Vistin Pharma
Notice of Dividend Amount
2026
May 22
AGM Information
2026
May 20
Report Publication Announcement
2026
May 20
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 28
Remuneration Information
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Annual Report (ESEF)
2026
Apr 28
Regulatory Filings
2026
Apr 28
AGM Information
2026
Apr 28